Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Depreciation & Amortization (CF) (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $246000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 38.98% to $246000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.2 million, a 47.8% increase, with the full-year FY2024 number at $1.1 million, up 11.38% from a year prior.
  • Depreciation & Amortization (CF) was $246000.0 for Q3 2025 at SANUWAVE Health, up from $179000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $575000.0 in Q4 2024 to a low of $136000.0 in Q1 2024.
  • A 3-year average of $255181.8 and a median of $248000.0 in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest YoY gain for Depreciation & Amortization (CF) was 131.85% in 2024; the steepest drop was 47.49% in 2024.
  • SANUWAVE Health's Depreciation & Amortization (CF) stood at $248000.0 in 2023, then surged by 131.85% to $575000.0 in 2024, then crashed by 57.22% to $246000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Depreciation & Amortization (CF) are $246000.0 (Q3 2025), $179000.0 (Q2 2025), and $209000.0 (Q1 2025).